Aikou Okamoto

Minato, JP

Expertise in

conditions

Minato, JP

OverviewLocationsClinical Research

Overview

Aikou Okamoto practices in Minato, Japan. Okamoto is highly rated in 11 conditions, according to our data. Their top areas of expertise are Ovarian Cancer, Cervical Cancer, Endometrial Cancer, Hysterectomy, and Lymphadenectomy.

Their clinical research consists of co-authoring 287 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Minato, Japan

Other Locations

Tokyo, Japan

Minato, Japan

Komae, Japan

Shiba, Japan

Sendai, 9808579, Japan

St. Luke's International Hospital, Sapporo, Japan

Himeji, Japan

Japan

Osaka, Japan

Nishi, 1058461, Japan

Toyoake, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer

Enrollment Status: Active_not_recruiting

Publish Date: September 15, 2025

Intervention Type: Drug

Study Drugs: Tisotumab Vedotin, Topotecan, Vinorelbine, Gemcitabine, Irinotecan, Pemetrexed

Study Phase: Phase 3

A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)

Enrollment Status: Active_not_recruiting

Publish Date: December 10, 2024

Intervention Type: Other, Drug, Biological

Study Drugs: Bevacizumab, Carboplatin, Docetaxel, Gemcitabine Hydrochloride, Paclitaxel

Study Phase: Phase 3

Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)

Enrollment Status: Active_not_recruiting

Publish Date: May 03, 2024

Intervention Type: Other

Study Phase: Not Applicable

View 2 Less Clinical Trials

286 Total Publications

Association between women's weight gain during their infancy and being overweight or underweight in adulthood: a retrospective cohort study.

Journal: Journal of developmental origins of health and disease

Published: September 01, 2025

View All 286 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Okamoto's expertise for a condition

ConditionClose